-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$82.69106.47% Upside
Recent Analyst Forecasts and Stock Ratings
Legend Biotech Corporation Frequently Asked Questions
-
What analysts cover Legend Biotech Corporation?
Legend Biotech Corporation has been rated by research analysts at Cantor Fitzgerald, BTIG, Johnson Rice, Barclays, Redburn Partners, Piper Sandler in the past 90 days.